Travasol Articles
Dyax start Ph III trials of angiodema drug
19 December 2005
Halozyme/Baxter get FDA appro for Hylenex
12 December 2005
Sanofi's Taxotere gets priority review for advanced gastric cancer
12 December 2005
Organon USa to distribute Sanofi-Aventis' Anzemet
12 December 2005
Strong animal data for KDI in PD
5 December 2005
Antares to supply injectables to Teva
5 December 2005
ISTA publishes Vitrase Ph II trial results
12 September 2005
VaxGen publishes results of smallpox vaccine study
12 September 2005
Tercica responds to citizen petition
5 September 2005
Lipid Sciences initiates HDL collaboration
5 September 2005
Baxter gets FDA go ahead for Ceftriaxone
5 September 2005
FDA OKs Tercica's Increlex for primary IGFD
5 September 2005
United Thera: EU MRP ends for Remodulin
22 August 2005
Orthogen touts COX 2 inhibitor rival
22 August 2005
Insmed files Citizen Petition to block Tercica's Increlex
22 August 2005
Berlex awarded HPG Magnevist contract
15 August 2005
Organon's Follistim launched in Japan
15 August 2005
Complex result in Forteo vs Fosamax trial
15 August 2005
Amylin's 2nd-qtr loss narrows 32% to $26.6M
15 August 2005
Cytogen's 2nd qtr loss widens 75%
15 August 2005
Hospira ships first order of ceftriaxone
1 August 2005
UPDATE: MGI Pharma makes $178M bid for Guilford, plus assuming $69.4M convertible debt
1 August 2005
Gilead's 2nd-qtr revenues up 55%
1 August 2005
FDA accepts Spectrum's ANDA for cancer drug
1 August 2005
Hospira ships first order of ceftriaxone inj
25 July 2005
Vical and Inovio start cancer dosing trial
25 July 2005
Roche and Trimeris file sNDA for needle-free Fuzeon
25 July 2005
Genzyme guidance upped on good 2nd qtr
25 July 2005
Novo Nordisk debuts GlucaGen HypoKit
18 July 2005
Study finds Botox potential for urinary incontinence
18 July 2005
Genta files Letter of Intent for Genasense MAA
11 July 2005
Genta starts NDA for Genasense Injection
11 July 2005
Nastech starts Ph I trial of PTH1-34
11 July 2005
Isolagen launches new business model on the back of ACE; is poised for global expansion
11 July 2005
Cephalon signs Vivitrex deal with Alkermes
4 July 2005
Cubist shares jump on Ph III Cubicin trial
4 July 2005
No allergic reactions from Halozyme's rHuPH20
4 July 2005
Japan stock market week to June 20
27 June 2005
US speciality pharmacy rate "up 22.5% in 2005"
27 June 2005
Genta's Genasense combo sees strong efficacy data
20 June 2005
FDA OKs Spectrum's generic carboplatin
20 June 2005
Cephalon buys into cancer therapy sector
20 June 2005
Positive comparative data on Copaxone
20 June 2005
Positive results for Sanofi-Aventis' Lantus
20 June 2005
Japan stock market week to June 6
13 June 2005
Alkermes' NDA for Vivtrex accepted by the US FDA
6 June 2005
Tercica moves to block Insmed growth drug in USA
6 June 2005
Guilford loses 20% of workforce over Gliadel
6 June 2005
New indication for AstraZeneca's Merrem
6 June 2005
Japan stock market week to May 30
6 June 2005
Three Rivers buys Amphotec/Amphocil rights
6 June 2005
pSivida and EpiTan report on Melanotan study
23 May 2005
Health Canada clears Eyetech/Pfizer's Macugen
23 May 2005
Guilford's Aggrastat sees strong results
23 May 2005
Eyetech sees new indication for Macugen
23 May 2005
Genta updates on Ph III Genasense trial
23 May 2005
Generex to debut Oral-lyn in S America
16 May 2005
Halozyme reduces IOP in animals
16 May 2005
Research sheds light on Pharmacyclics' Xcytrin
16 May 2005
Eyetech: mouse data confirms Macugen's mechanism
16 May 2005
FDA clears APP's generic Esmolol
16 May 2005
Eyetech affirms Macugen's safety profile
16 May 2005
Priority review for Tercica's growth agent
9 May 2005
Millennium's 1st-qtr losses narrow
9 May 2005
Eli Lilly/Amylin's diabetes drug gets FDA OK
9 May 2005
Novartis files Exjade in USA and EU
9 May 2005
NsGene's capital base strengthened
9 May 2005
Berlex, Premier in new MRI contrast deal
9 May 2005
Genzyme's 1st-qtr revenues up 28%
25 April 2005
Guilford restarts Aquavan program
25 April 2005
Genasense shows strong combination performance
25 April 2005
Japan stock market week to April 18
25 April 2005
1st-qtr net doubles for Akzo Nobel
25 April 2005
MGI reports 241% 1st qtr revenue jump
25 April 2005
Chugai gets approval for toclizumab
25 April 2005
Migraine sufferers dissatisfied with current therapies
25 April 2005
Insmed's SomatoKine granted priority review by US FDA
22 April 2005
Alkermes' Vivitrex shows good performance
18 April 2005
Ferring debuts new fertility treatment in USA
18 April 2005
Bayer Corp starts Ph III evaluation of Trasyol
18 April 2005
Zeltia's Yondelis enters Phase III
11 April 2005
Alkermes: NDA for alcoholism drug
11 April 2005
Serono and Syntonix: interferon inhaler deal
11 April 2005
KSL and Kagoshima Univ give transdermal delivery a boost
11 April 2005
FDA approves GSK's sNDA for Zofran
4 April 2005
Pfizer and Coley sign deal for cancer drugs
4 April 2005
Japan stock market week to March 7
14 March 2005
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
